Browsing by Author Clarke, Stephen

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 190  next >
Issue DateTitleAuthor(s)Citation
2012Activation of Thermogenesis in Brown Adipose Tissue and Dysregulated Lipid Metabolism Associated with Cancer Cachexia in MiceClarke, Stephen; Robertson, Graham; Burg, Dominic; Cooney, Gregory; Lockie, Sarah; Moore, Melissa; Oldfield, Brian J; Painter, Arran; Taylor, Ryland; Tsoli, Maria; Turner, Nigel; Warren, Alessandra; Northern Clinical School: Kolling Institute; Concord Clinical School: ANZAC Research InstituteActivation of Thermogenesis in Brown Adipose Tissue and Dysregulated Lipid Metabolism Associated with Cancer Cachexia in Mice, Cancer Research, vol.72, 17, 2012,pp 4372-4382
2016The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trialsChan, David; Clarke, Stephen; Khasraw, Mustafa; Lee, Adrian; Li, Bob; Marx, Gavin; Pavlakis, Nick; Barnes, Tristan; Drilon, Alexander D.; Kris, Mark G.; Naidoo, Jarushka; Rudin, Charles M.; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Central Clinical School: Pathology; SAHCS: Medicine; Northern Clinical School: MedicineThe addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials, Lung Cancer, vol.102, N/A, 2016,pp 21-27
2006Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity.Beale, Philip; Clarke, Stephen; Friedlander, Michael; Goldstein, David; Michael, Michael; Mitchell, Paul L.; Thomson, Jacquelyn A.; White, Shane; Zalcberg, John; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteAddition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity., Clinical Colorectal Cancer, vol.6,(2),2006,pp 146-151
2010Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?Beale, Philip; Blinman, Prunella; Clarke, Stephen; Duric, Vlatka; Hudson, Malcolm; Stockler, Martin; Boyce, Adam; Briscoe, Karen; Goldstein, David; Nowak, Anna K.; Central Clinical School: Medicine; School of Public Health: Public Health; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?, European Journal of Cancer, vol.46, 10, 2010,pp 1800-1807
2009Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary settingBeale, Philip; Bokey, Elie; Chapuis, Pierre; Clarke, Stephen; Dent, Owen; Central Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: SurgeryAdjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting, ANZ Journal of Surgery, vol.79, 10,pp 685-692
2015Adjuvant Iodine (131) Lipiodol after Resection of Hepatocellular CarcinomaClarke, Stephen; Furtado, Ruelan V; Ha, Leo; Sandroussi, Charbel; Northern Clinical School: Kolling InstituteAdjuvant Iodine (131) Lipiodol after Resection of Hepatocellular Carcinoma, Journal of Oncology, vol.2015, N/A, 2015,pp 1-7
2006Advances in the adjuvant treatment of colorectal cancer.Clarke, Stephen; Iyer, Shoba; Nordman, I; Joshua, Anthony M.; Concord Clinical School: ANZAC Research Institute; Medicine; Central Clinical School: MedicineAdvances in the adjuvant treatment of colorectal cancer., ANZ Journal of Surgery, vol.76,(5),2006,pp 373-380
2014Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinomaClarke, Stephen; Gananadha, Sivakumar; Gill, Anthony; Hugh, Thomas; Neale, Michael; Pavlakis, Nick; Puttaswamy, Vikram; Samra, Jaswinder; Wang, Frank; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Pathology; Northern Clinical School: Surgery; Northern Clinical School: Surgery; Northern Clinical School: Medicine; Northern Clinical School: Surgery; Northern Clinical School: Surgery; Northern Clinical School: MedicineAdverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma, Annals of Surgical Oncology, vol.21, 6, 2014,pp 1937-1947
2006Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.Clarke, Stephen; Li, Kong; Rivory, Laurent; Sharma, Rohini; Hoskins, Janelle M.; Concord Clinical School: ANZAC Research Institute; School of Medical Sciences: Pharmacology; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium InstituteAltered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients., British Journal of Clinical Pharmacology, vol.63,(1),2006,pp 67-74
2010The alternatively spliced murine pregnane X receptor isoform, mPXRΔ171–211 exhibits a repressive actionClarke, Stephen; Polly, Patsie; Robertson, Graham; Carradin, Anthony P; Matic, Marko; Tsoli, Maria; Northern Clinical School: Kolling Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteThe alternatively spliced murine pregnane X receptor isoform, mPXRΔ171–211 exhibits a repressive action, The International Journal of Biochemistry and Cell Biology, vol.42, 5, 2010,pp 672-682
2016Analytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month periodClarke, Stephen; Amirkhani, Ardeshir; Molloy, Mark P; Pascovici, Dana; Song, Xiaomin; Wu, Jemma X.; Xavier, Dylan; Zaw, Thiri; Northern Clinical School: Kolling InstituteAnalytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month period, Proteomics, vol.16, 15-16, 2016,pp 2118-2127
2005Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.Beale, Philip; Clarke, Stephen; Friedlander, Michael; Goldstein, David; Michael, Michael; Mitchell, P.; White, Shane; Zalcberg, John; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteAustralian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients., British Journal of Cancer, vol.92,(5),2005,pp 832-837
2013An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (AvastinTM) [ASCENT]Clarke, Stephen; Burge, Matt; Cordwell, Cassandra; Gibbs, Peter; Reece, William; Tebbutt, Niall; Concord Clinical School: MedicineAn Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (AvastinTM) [ASCENT], BMC Cancer, vol.13, N/A, 2013,pp 1-7
2003Baseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative ChemotherapyCharles (nee Slaviero), Kellie; Clarke, Stephen; Read, Jane; Rivory, Laurent; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: MedicineBaseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative Chemotherapy, Nutrition and Cancer: an international journal, vol.46,(2),2003,pp 148-157
2008Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III studyClarke, Stephen; Diaz-Rubio, Eduardo; et, al; Figer, Arie; Koski, Sherryl; Lichinitser, Mikhail; Rivera, Fernando; Saltz, Leonard B.; Scheithauer, Werner; Wong, Ralph; Yang, Tsai-Shen; Northern Clinical School: Kolling InstituteBevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study, Journal of Clinical Oncology, vol.26, 12, 2008,pp 2013-2019
2012Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialClarke, Stephen; Cartwright, Thomas; Cunningham, David; De Gramont, A.; et al, Various; Hecht, J; Im, Seock-Ah; Moore, Malcolm; Rivera, Fernando; Schmoll, Hans-Joachim; Tabernero, Josep; Van Cutsem, E; Concord Clinical School: MedicineBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial, Lancet Oncology, vol.13, 12, 2012,pp 1225-1233
2010Beyond Conventional Cancer Treatments: The Use of Complementary Therapies During Cancer Treatment: Implications for CliniciansBrown, Darrin; Carbonara, Stephen; Clarke, Stephen; Kissane, Rachel; McLachlan, Andrew; Pharmacy; Pharmacy; Northern Clinical School: Kolling Institute; Pharmacy; PharmacyBeyond Conventional Cancer Treatments: The Use of Complementary Therapies During Cancer Treatment: Implications for Clinicians in When Cancer Crosses Disciplines: A Physicians Handbook, Imperial College Press, 2010, pp. 285-315
2015Biomarkers in Metastatic Colorectal CancerCharles (nee Slaviero), Kellie Anne; Clarke, Stephen; Diakos, Connie; Howell, Viive; Chua, Wei; School of Medical Sciences: Pharmacology; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteBiomarkers in Metastatic Colorectal Cancer in Biomarkers in Cancer, Springer, 2015, pp. 601-630
2012Body image as a predictor of psychopathology in surgical patients with colorectal diseaseBokey, Elie (Les); Bullen, Tracey; Clarke, Stephen; Lawsin, Catalina; Patel (nee Chauhan), Deepa; Sharpe, Louise; Central Clinical School: Surgery; Psychology; Concord Clinical School: Medicine; Psychology; Psychology; PsychologyBody image as a predictor of psychopathology in surgical patients with colorectal disease, Journal of Psychosomatic Research, vol.73, 6, 2012,pp 459-463
2013BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch SyndromeClarke, Stephen; Gill, Anthony; Capper, David; Chou, Angela; Clarkson, Adele; Clendenning, Mark; et al, Various; Mead, Scott; Rosty, Christophe; Sioson, Loretta; Toon, Christopher; Walsh, Michael; Walters, Rhiannon; Young, Joanne; Concord Clinical School: Medicine; Northern Clinical School: PathologyBRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch Syndrome, American Journal of Surgical Pathology, vol.37, 10, 2013,pp 1592-1602